The Stimulating Peripheral Activity to Relieve Conditions (SPARC) program at the NIH Common Fund has released two Request-For-Information (RFI) calls soliciting public input on device-based clinical neuromodulation studies, specifically involving peripheral or spinal cord neuromodulation of organ function. One RFI, NOT-RM-17-023, seeks input from surgeons, interventionalists and other relevant clinicians. The other, NOT-RM-17-015, targets industry stakeholders. The overall goal of these RFIs is to obtain strategic input on ways to improve both the therapeutic potential and scientific impact of clinical studies involving neuromodulation devices.
Clinician perspectives are needed on various topics such as the state of surgical planning and access tools, clinical considerations related to device design and functionality, and the potential use of clinical settings to collect physiology data for research. Input from industry scientists and engineers is sought on ways to establish effective public-private partnerships around clinical studies, to pursue new therapeutic opportunities using existing technology and to explore the use of devices with expanded research capabilities to maximize data yield from clinical device-based studies.
As explained in the RFIs, responses can be submitted via email SPARC_TPNI@mail.nih.gov, through tele-conference meetings with the SPARC team requested at http://nihsparc.setmore.com, or through voice mail messages left at the provided telephone number. This RFI will close on December 1, 2017.
Questions? Contact the SPARC POC.